全球兽医肿瘤市场研究报告 - 2023 年至 2030 年行业分析、规模、份额、成长、趋势和预测

预计到 2030 年，全球兽医肿瘤市场的市场规模将从 2022 年的 3097.2 亿美元达到近 10,248.2 亿美元，2023-2030 年研究期间CAGR为 14.22%。

兽医肿瘤学基本上是对患有癌症的宠物进行诊断和治疗。狗和猫更容易患皮肤癌和骨癌等疾病。它使用伤害、饥饿、水合、卫生、幸福、行动量表来与宠物主人讨论和确定他们的生活品质，然后再做出治疗这些疾病的安乐死决定。导致宠物罹患癌症的因素包括动物皮肤持续暴露在阳光和外部环境下、病毒以及烟雾、杀虫剂、紫外线和放射性废物等致癌物质。

市场动态：

淋巴瘤、皮肤癌、肥大细胞癌等癌症疾病盛行率的增加导致对兽医肿瘤学市场的高需求。越来越多的宠物收养和对宠物健康的日益关注正在激增对该市场的需求。用于评估肿瘤药物安全性和有效性的兽医临床研究数量的增加正在促进对该市场的需求。此外，私人和政府组织对动物护理中心的资金增加以及宠物肿瘤治疗研发活动的增加正在推动该市场的需求。此外，在研究期间，兽医肿瘤治疗领域主要製造公司的存在以及动物保健支出的增加也推动了市场的成长。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具还对全球兽医肿瘤学市场的每个细分市场进行了包容性评估。兽医肿瘤学行业的成长和趋势为本研究提供了整体方法。

区域分析：

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲兽医肿瘤学市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。兽医肿瘤市场的主要参与者包括 PetCure Oncology、Zoetis Inc.、Karyopharm Therapeutics, Inc.、Varian Medical Systems、Accuray Incorporated、Boehringer Ingelheim GmbH、Elanco、One Health、Regeneus Ltd。竞争格局，包括各种策略发展，例如关键併购、未来产能、合作伙伴关係、财务概况、合作、新产品开发、新产品发布和其他发展。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

目录

第一章：前言

• 报告说明
  • 客观的
  • 目标受众
  • 独特的销售主张 (USP) 和产品
• 研究范围
• 研究方法论
  • 市场研究过程
  • 市场研究方法论

第 2 章：执行摘要

• 市集亮点
• 全球市场概况

第 3 章：兽医肿瘤学 - 产业分析

• 简介 - 市场动态
• 市场驱动因素
• 市场限制
• 机会
• 产业动态
• 波特五力分析
• 市场吸引力分析
  • 按治疗方法进行的市场吸引力分析
  • 按动物类型分類的市场吸引力分析
  • 按癌症类型分類的市场吸引力分析
  • 市场吸引力分析：按地区

第 4 章：价值链分析

• 价值链分析
• 原料分析
  • 原料清单
  • 原料厂商清单
  • 主要原物料价格走势
• 潜在买家名单
• 行销管道
  • 直效行销
  • 间接行销
  • 行销通路发展趋势

第 5 章：COVID-19 爆发的影响分析

第 6 章：全球兽医肿瘤市场分析：依治疗分类

• 治疗概述
• 历史和预测数据
• 治疗分析
• 手术
• 放射治疗
• 化疗
• 免疫疗法
• 其他的

第 7 章：全球兽医肿瘤学市场分析：按动物类型

• 依动物类型概述
• 历史和预测数据
• 依动物类型分析
• 犬类
• 猫科动物

第 8 章：全球兽医肿瘤学市场销售分析：按癌症类型

• 按癌症类型概述
• 历史和预测数据
• 按癌症类型分析
• 淋巴瘤
• 肥大细胞癌
• 乳癌和鳞状细胞癌
• 其他的

第 9 章：全球兽医肿瘤学市场销售分析：按地理位置

• 区域展望销售分析
• 简介 销售分析
• 北美销售分析
  • 概述、历史和预测销售分析
  • 北美按细分市场销售分析
  • 北美按国家销售分析
  • 美国销售分析
  • 加拿大销售分析
  • 墨西哥销售分析
• 欧洲销售分析
  • 概述、历史和预测销售分析
  • 欧洲按细分市场销售分析
  • 欧洲按国家销售分析
  • 英国销售分析
  • 法国销售分析
  • 德国销售分析
  • 义大利销售分析
  • 俄罗斯销售分析
  • 欧洲其他地区销售分析
• 亚太地区销售分析
  • 概述、历史和预测销售分析
  • 亚太地区按细分市场销售分析
  • 亚太地区国家/地区销售分析
  • 中国销售分析
  • 印度销售分析
  • 日本销售分析
  • 韩国销售分析
  • 澳洲销售分析
  • 亚太地区其他地区销售分析
• 拉丁美洲销售分析
  • 概述、历史和预测销售分析
  • 拉丁美洲按细分市场销售分析
  • 拉丁美洲按国家销售分析
  • 巴西销售分析
  • 阿根廷销售分析
  • 秘鲁销售分析
  • 智利销售分析
  • 拉丁美洲其他地区销售分析
• 中东和非洲销售分析
  • 概述、历史和预测销售分析
  • 中东和非洲按细分市场销售分析
  • 中东和非洲国家销售分析
  • 沙乌地阿拉伯销售分析
  • 阿联酋销售分析
  • 以色列销售分析
  • 南非销售分析
  • 中东其他地区和非洲销售分析

第 10 章：兽医肿瘤公司的竞争格局

• 兽医肿瘤学市场竞争
• 伙伴关係/协作/协议
• 併购
• 新产品发布
• 其他发展

第 11 章：公司简介

• 十大公司股票分析
• 市场集中度
• PetCure Oncology
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Zoetis Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Karyopharm Therapeutics Inc.
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Varian Medical Systems
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Accuray Incorporated
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Boehringer Ingelheim GmbH
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Elanco
• 公司简介
• 公司收入
• 产品
• 最近的发展
• One Health
• 公司简介
• 公司收入
• 产品
• 最近的发展
• Regeneus Ltd
• 公司简介
• 公司收入
• 产品
• 最近的发展

注意 - 在公司概况中，财务详细资讯和近期发展视情况而定，或者如果是私人公司，则可能不包括在内

The global demand for Veterinary Oncology Market is presumed to reach the market size of nearly USD 1024.82 BN by 2030 from USD 309.72 BN in 2022 with a CAGR of 14.22% under the study period 2023 - 2030.

Veterinary oncology is basically the diagnosis and treatment of pets suffering from cancer. Dogs and cats are more prone to develop diseases like skin cancer and bone cancer. It uses the Hurt Hunger Hydration Hygiene Happiness Mobility Scale to discuss and identify their quality of life with pet owners before making a euthanasia decision for the treatment of these diseases. Factors that lead to cancer in pets include constant exposure of animal skin to the sun and external environment, viruses, and carcinogens such as smoke, pesticides, UV light and radioactive waste.

MARKET DYNAMICS:

The increase in the prevalence of cancer diseases such as lymphoma, skin cancer, mast cell cancer etc. is leading to high demand for the veterinary oncology market. Rising pet adoption and a growing focus on pet health are surging the demand for this market. An increase in the number of veterinary clinical studies for evaluating the safety and efficiency of oncology drugs is fostering the demand for this market. In addition, an increase in funding from private & government organizations for animal care centres and a rise in R&D activities for oncology treatment in pets are boosting the demand for this market. Moreover, the presence of key manufacturing companies in veterinary oncology treatment and rise in animal healthcare expenditure is also propelling the market growth during the study.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of veterinary oncology. The growth and trends of veterinary oncology industry provide a holistic approach to this study.

MARKET SEGMENTATION:

This section of the veterinary oncology market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Therapy

• Surgery
• Radiotherapy
• Chemotherapy
• Immunotherapy
• Others

By Animal Type

• Canine
• Feline

By Cancer Type

• Lymphoma
• Mast Cell Cancer
• Mammary And Squamous Cell Cancer
• Others

REGIONAL ANALYSIS:

This section covers the regional outlook, which accentuates current and future demand for the Veterinary Oncology market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Veterinary Oncology market include PetCure Oncology, Zoetis Inc., Karyopharm Therapeutics, Inc., Varian Medical Systems, Accuray Incorporated, Boehringer Ingelheim GmbH, Elanco, One Health, Regeneus Ltd. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

TABLE OF CONTENTS

1 . PREFACE

• 1.1. Report Description
  • 1.1.1. Objective
  • 1.1.2. Target Audience
  • 1.1.3. Unique Selling Proposition (USP) & offerings
• 1.2. Research Scope
• 1.3. Research Methodology
  • 1.3.1. Market Research Process
  • 1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY

• 2.1. Highlights of Market
• 2.2. Global Market Snapshot

3 . VETERINARY ONCOLOGY - INDUSTRY ANALYSIS

• 3.1. Introduction - Market Dynamics
• 3.2. Market Drivers
• 3.3. Market Restraints
• 3.4. Opportunities
• 3.5. Industry Trends
• 3.6. Porter's Five Force Analysis
• 3.7. Market Attractiveness Analysis
  • 3.7.1 Market Attractiveness Analysis By Therapy
  • 3.7.2 Market Attractiveness Analysis By Animal Type
  • 3.7.3 Market Attractiveness Analysis By Cancer Type
  • 3.7.4 Market Attractiveness Analysis By Region

4 . VALUE CHAIN ANALYSIS

• 4.1. Value Chain Analysis
• 4.2. Raw Material Analysis
  • 4.2.1. List of Raw Materials
  • 4.2.2. Raw Material Manufactures List
  • 4.2.3. Price Trend of Key Raw Materials
• 4.3. List of Potential Buyers
• 4.4. Marketing Channel
  • 4.4.1. Direct Marketing
  • 4.4.2. Indirect Marketing
  • 4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK

6 . GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY THERAPY

• 6.1 Overview by Therapy
• 6.2 Historical and Forecast Data
• 6.3 Analysis by Therapy
• 6.4 Surgery Historic and Forecast Sales by Regions
• 6.5 Radiotherapy Historic and Forecast Sales by Regions
• 6.6 Chemotherapy Historic and Forecast Sales by Regions
• 6.7 Immunotherapy Historic and Forecast Sales by Regions
• 6.8 Others Historic and Forecast Sales by Regions

7 . GLOBAL VETERINARY ONCOLOGY MARKET ANALYSIS BY ANIMAL TYPE

• 7.1 Overview by Animal Type
• 7.2 Historical and Forecast Data
• 7.3 Analysis by Animal Type
• 7.4 Canine Historic and Forecast Sales by Regions
• 7.5 Feline Historic and Forecast Sales by Regions

8 . GLOBAL VETERINARY ONCOLOGY MARKET SALES ANALYSIS BY CANCER TYPE

• 8.1 Overview by Cancer Type
• 8.2 Historical and Forecast Data
• 8.3 Analysis by Cancer Type
• 8.4 Lymphoma Historic and Forecast Sales by Regions
• 8.5 Mast Cell Cancer Historic and Forecast Sales by Regions
• 8.6 Mammary And Squamous Cell Cancer Historic and Forecast Sales by Regions
• 8.7 Others Historic and Forecast Sales by Regions

9 . GLOBAL VETERINARY ONCOLOGY MARKET SALES ANALYSIS BY GEOGRAPHY

• 9.1. Regional Outlook Sales Analysis
• 9.2. Introduction Sales Analysis
• 9.3. North America Sales Analysis
  • 9.3.1. Overview, Historic and Forecast Sales Analysis
  • 9.3.2. North America By Segment Sales Analysis
  • 9.3.3. North America By Country Sales Analysis
  • 9.3.4. United State Sales Analysis
  • 9.3.5. Canada Sales Analysis
  • 9.3.6. Mexico Sales Analysis
• 9.4. Europe Sales Analysis
  • 9.4.1. Overview, Historic and Forecast Sales Analysis
  • 9.4.2. Europe by Segment Sales Analysis
  • 9.4.3. Europe by Country Sales Analysis
  • 9.4.4. United Kingdom Sales Analysis
  • 9.4.5. France Sales Analysis
  • 9.4.6. Germany Sales Analysis
  • 9.4.7. Italy Sales Analysis
  • 9.4.8. Russia Sales Analysis
  • 9.4.9. Rest Of Europe Sales Analysis
• 9.5. Asia Pacific Sales Analysis
  • 9.5.1. Overview, Historic and Forecast Sales Analysis
  • 9.5.2. Asia Pacific by Segment Sales Analysis
  • 9.5.3. Asia Pacific by Country Sales Analysis
  • 9.5.4. China Sales Analysis
  • 9.5.5. India Sales Analysis
  • 9.5.6. Japan Sales Analysis
  • 9.5.7. South Korea Sales Analysis
  • 9.5.8. Australia Sales Analysis
  • 9.5.9. Rest Of Asia Pacific Sales Analysis
• 9.6. Latin America Sales Analysis
  • 9.6.1. Overview, Historic and Forecast Sales Analysis
  • 9.6.2. Latin America by Segment Sales Analysis
  • 9.6.3. Latin America by Country Sales Analysis
  • 9.6.4. Brazil Sales Analysis
  • 9.6.5. Argentina Sales Analysis
  • 9.6.6. Peru Sales Analysis
  • 9.6.7. Chile Sales Analysis
  • 9.6.8. Rest of Latin America Sales Analysis
• 9.7. Middle East & Africa Sales Analysis
  • 9.7.1. Overview, Historic and Forecast Sales Analysis
  • 9.7.2. Middle East & Africa by Segment Sales Analysis
  • 9.7.3. Middle East & Africa by Country Sales Analysis
  • 9.7.4. Saudi Arabia Sales Analysis
  • 9.7.5. UAE Sales Analysis
  • 9.7.6. Israel Sales Analysis
  • 9.7.7. South Africa Sales Analysis
  • 9.7.8. Rest Of Middle East And Africa Sales Analysis

10 . COMPETITIVE LANDSCAPE OF THE VETERINARY ONCOLOGY COMPANIES

• 10.1. Veterinary Oncology Market Competition
• 10.2. Partnership/Collaboration/Agreement
• 10.3. Merger And Acquisitions
• 10.4. New Product Launch
• 10.5. Other Developments

11 . COMPANY PROFILES OF VETERINARY ONCOLOGY INDUSTRY

• 11.1. Top 10 Company Share Analysis
• 11.2. Market Concentration Rate
• 11.3. PetCure Oncology
  • 11.3.1. Company Overview
  • 11.3.2. Company Revenue
  • 11.3.3. Products
  • 11.3.4. Recent Developments
• 11.4. Zoetis Inc.
  • 11.4.1. Company Overview
  • 11.4.2. Company Revenue
  • 11.4.3. Products
  • 11.4.4. Recent Developments
• 11.5. Karyopharm Therapeutics Inc.
  • 11.5.1. Company Overview
  • 11.5.2. Company Revenue
  • 11.5.3. Products
  • 11.5.4. Recent Developments
• 11.6. Varian Medical Systems
  • 11.6.1. Company Overview
  • 11.6.2. Company Revenue
  • 11.6.3. Products
  • 11.6.4. Recent Developments
• 11.7. Accuray Incorporated
  • 11.7.1. Company Overview
  • 11.7.2. Company Revenue
  • 11.7.3. Products
  • 11.7.4. Recent Developments
• 11.8. Boehringer Ingelheim GmbH
  • 11.8.1. Company Overview
  • 11.8.2. Company Revenue
  • 11.8.3. Products
  • 11.8.4. Recent Developments
• 11.9. Elanco
  • 11.9.1. Company Overview
  • 11.9.2. Company Revenue
  • 11.9.3. Products
  • 11.9.4. Recent Developments
• 11.10. One Health
  • 11.10.1. Company Overview
  • 11.10.2. Company Revenue
  • 11.10.3. Products
  • 11.10.4. Recent Developments
• 11.11. Regeneus Ltd
  • 11.11.1. Company Overview
  • 11.11.2. Company Revenue
  • 11.11.3. Products
  • 11.11.4. Recent Developments

Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

• Market Snapshot
• Drivers : Impact Analysis
• Restraints : Impact Analysis
• List of Raw Material
• List of Raw Material Manufactures
• List of Potential Buyers
• Analysis by Therapy (USD MN)
• Surgery Market Sales by Geography (USD MN)
• Radiotherapy Market Sales by Geography (USD MN)
• Chemotherapy Market Sales by Geography (USD MN)
• Immunotherapy Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Analysis Market by Animal Type (USD MN)
• Canine Market Sales by Geography (USD MN)
• Feline Market Sales by Geography (USD MN)
• Analysis by Cancer Type (USD MN)
• Lymphoma Market Sales by Geography (USD MN)
• Mast Cell Cancer Market Sales by Geography (USD MN)
• Mammary And Squamous Cell Cancer Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Veterinary Oncology Market Sales by Geography (USD MN)
• North America Market Analysis (USD MN)
• United State Market Analysis (USD MN)
• Canada Market Analysis (USD MN)
• Mexico Market Analysis (USD MN)
• Europe Market Analysis (USD MN)
• Europe Market Estimate by Country (USD MN)
• United Kingdom Market Analysis (USD MN)
• France Market Analysis (USD MN)
• Germany Market Analysis (USD MN)
• Italy Market Analysis (USD MN)
• Russia Market Analysis (USD MN)
• Spain Market Analysis (USD MN)
• Rest of Europe Market Analysis (USD MN)
• Asia Pacific Market Analysis (USD MN)
• China Market Analysis (USD MN)
• Japan Market Analysis (USD MN)
• India Market Analysis (USD MN)
• South Korea Market Analysis (USD MN)
• Australia Market Analysis (USD MN)
• Rest of Asia Pacific Market Analysis (USD MN)
• Latin America Market Analysis (USD MN)
• Brazil Market Analysis (USD MN)
• Argentina Market Analysis (USD MN)
• Peru Market Analysis (USD MN)
• Chile Market Analysis (USD MN)
• Rest of Latin America Market Analysis (USD MN)
• Middle East & Africa Market Analysis (USD MN)
• Saudi Arabia Market Analysis (USD MN)
• UAE Market Analysis (USD MN)
• Israel Market Analysis (USD MN)
• South Africa Market Analysis (USD MN)
• Rest of Middle East and Africa Market Analysis (USD MN)
• Partnership/Collaboration/Agreement
• Mergers And Acquisition

LIST OF FIGURES

• Research Scope of Veterinary Oncology Report
• Market Research Process
• Market Research Methodology
• Global Veterinary Oncology Market Size, by Region (USD MN)
• Porters Five Forces Analysis
• Market Attractiveness Analysis by Therapy
• Market Attractiveness Analysis by Animal Type
• Market Attractiveness Analysis by Cancer Type
• Market Attractiveness Analysis by Region
• Value Chain Analysis
• Global Market Analysis by Therapy (USD MN)
• Surgery Market Sales by Geography (USD MN)
• Radiotherapy Market Sales by Geography (USD MN)
• Chemotherapy Market Sales by Geography (USD MN)
• Immunotherapy Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market Analysis by Animal Type (USD MN)
• Canine Market Sales by Geography (USD MN)
• Feline Market Sales by Geography (USD MN)
• Global Market Analysis by Cancer Type (USD MN)
• Lymphoma Market Sales by Geography (USD MN)
• Mast Cell Cancer Market Sales by Geography (USD MN)
• Mammary And Squamous Cell Cancer Market Sales by Geography (USD MN)
• Others Market Sales by Geography (USD MN)
• Global Market by Revenue
• North America Market by Revenue
• Europe Market by Revenue
• Asia Pacific Market by Revenue
• Latin America Market by Revenue
• Middle East & Africa Market by Revenue
• Recent Development in Industry
• Top Company Share Analysis

Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.